This month, we explore the 125-year-old history of Abbott Laboratories and its most significant ... and was a practicing physician and owner of a drug store. Using the active part of a medicinal ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other stocks Jim Cramer is talking about before earnings. As earnings season kicks off ...

CNBC’s Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that’s been weighed down by ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE ... only 14% of drugs in clinical trials make it to FDA approval, according to Research from MIT, pushing the ...

They’re at the center of a legal battle with the makers of specialized formulas for preterm infants — north suburban-based Abbott Laboratories ... the U.S. Food and Drug Administration ...

Since my previous article, shares of Abbott Laboratories have returned 10% versus the 7% gains of the S&P 500 index. The healthcare company's sales and adjusted diluted EPS rose in the third quarter.

The Department of Justice announced an investigation into Abbott Laboratories' Michigan plant ... could result in the product being spoiled. The FDA announced on Wednesday their continued efforts ...

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Abbott Laboratories (NYSE:ABT), together with its subsidiaries, discovers, develops ...

A St. Louis jury handed Abbott Laboratories a win Thursday, deciding that Abbott, another company and a hospital were not ...

Investors happily greeted the latest news from Abbott Laboratories (NYSE: ABT) on Hump Day. After the storied healthcare company unveiled its third-quarter results, those folks traded its stock up ...

Nov 1 (Reuters) - Abbott Laboratories (ABT.N), opens new tab shares ... Editing by Shilpi Majumdar Healthcare & Pharmaceuticalscategory US FDA lifts clinical hold on Novavax's combo COVID-flu ...

Abbott Laboratories showcases robust financial performance with a notable increase in net earnings. Strategic acquisitions and product launches strengthen the company's market presence. Despite global ...